BeOne Medicines (ONC) Property, Plant & Equipment (Net) Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -13.32% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 17.12% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | -10.19% |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 24.11% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 12.18% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 3.92% |
| 10 | BeOne Medicines | - | - | 1.35 Bn | 2.65% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.65% |
| Dec 31, 2025 | 4.01% |
| Sep 30, 2025 | 4.17% |
| Jun 30, 2025 | 6.55% |
| Mar 31, 2025 | 12.74% |
| Dec 31, 2024 | 19.20% |
| Sep 30, 2024 | 32.68% |
| Jun 30, 2024 | 46.96% |
| Mar 31, 2024 | 53.23% |
| Dec 31, 2023 | 476.64% |
| Sep 30, 2023 | 72.75% |
| Jun 30, 2023 | 63.00% |
| Mar 31, 2023 | 48.14% |
| Dec 31, 2022 | -60.92% |
| Sep 30, 2022 | 51.27% |
| Jun 30, 2022 | 60.21% |
| Mar 31, 2022 | 67.05% |
| Dec 31, 2021 | 64.28% |
| Sep 30, 2021 | 54.79% |
| Jun 30, 2021 | 53.10% |
| Mar 31, 2021 | 55.60% |
| Dec 31, 2020 | 47.56% |
| Sep 30, 2020 | 28.57% |
| Jun 30, 2020 | 21.36% |
| Mar 31, 2020 | 21.50% |
| Dec 31, 2019 | 54.34% |
| Sep 30, 2019 | 103.57% |
| Jun 30, 2019 | 134.97% |
| Mar 31, 2019 | 156.92% |
| Dec 31, 2018 | 151.02% |
| Sep 30, 2018 | 101.12% |
| Jun 30, 2018 | 168.02% |
| Mar 31, 2018 | 150.59% |
| Dec 31, 2017 | 140.86% |
| Sep 30, 2017 | 234.19% |
| Jun 30, 2017 | 246.29% |
| Mar 31, 2017 | 298.90% |
| Dec 31, 2016 | 292.88% |